Aurora, CO 的 血液癌症 臨床試驗
8 項針對 血液癌症 的研究正在 Aurora（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
招募中3 期
- University of Colorado Cancer Center ( Site 0021), Aurora
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
招募中觀察性研究
- Children's Hospital Colorado, Aurora
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
招募中3 期
- University of Colorado, Aurora
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中觀察性研究
- Children's Hospital Colorado, Aurora
- University of Colorado Hospital, Aurora
Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
招募中觀察性研究
- Childrens Hospital of Colorado, Aurora
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
招募中3 期
- Children's Hospital Colorado, Aurora
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
招募中1 期
- University of Colorado, Aurora
其他城市的 血液癌症 試驗
- Houston, TX46 項研究
- New York City, NY26 項研究
- Boston, MA25 項研究
- Washington, DC19 項研究
- Seattle, WA18 項研究
- Baltimore, MD18 項研究
- Los Angeles, CA17 項研究
- Durham, NC16 項研究
- Chicago, IL15 項研究
- Philadelphia, PA14 項研究
- Edison, NJ13 項研究
- Nashville, TN13 項研究
Aurora 的其他研究
- 癌症（所有類型）35 項研究
- 大腸直腸癌32 項研究
- 非小細胞肺癌31 項研究
- 乳癌28 項研究
- 卵巢癌25 項研究
- 轉移性癌症25 項研究
- 第一型糖尿病23 項研究
- 肥胖症22 項研究
- 前列腺癌19 項研究
- 肺癌19 項研究
- 心臟衰竭18 項研究
- 黑色素瘤18 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。